Novo Nordisk

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments.

CEO

Maziar Mike Doustdar

CEOMaziar Mike Doustdar

Employees

68,794

Employees68,794

Headquarters

Bagsværd, Capital Region

HeadquartersBagsværd, Capital Region

Founded

1923

Founded1923

Employees

68,794

Employees68,794

NVO Key Statistics

Market cap

201.74B

Market cap201.74B

Price-Earnings ratio

11.38

Price-Earnings ratio11.38

Dividend yield

2.64%

Dividend yield2.64%

Average volume

10.12M

Average volume10.12M

High today

$45.97

High today$45.97

Low today

$45.27

Low today$45.27

Open price

$45.58

Open price$45.58

Volume

4.52M

Volume4.52M

52 Week high

$64.16

52 Week high$64.16

52 Week low

$35.12

52 Week low$35.12

NVO News

Simply Wall St 3h

Novo Nordisk Draws Fresh Valuation Focus, Is It Still 55% Below Fair Value? - simplywall.st

...

Seeking Alpha 7h

Novo Nordisk faces fresh setback as it halts two heart drug trials

Novo Nordisk (NVO) has halted two late-stage trials of its experimental heart drug ziltivekimab, adding to the drugmaker’s recent pipeline setbacks. The Danish...

TipRanks 18h

Novo Nordisk halts two trials testing ziltivekimab, Bloomberg reports

Novo Nordisk (NVO) has halted two trials testing if ziltivekimab, its experimental heart disease medicine, would help patients with heart failure, Ashleigh Furl...

More NVO News

The Motley Fool 19h

Eli Lilly Has Been on an Acquisition Spree. How Much Could Its Latest Deals Boost the Stock?

Eli Lilly's (LLY -0.88%) success in the GLP-1 weight-loss space highlights one of the biggest risks it faces right now. And it helps explain why the company lea...

TipRanks 22h

Novo Nordisk announces STEP Young phase 3 trial met its primary endpoint

Novo Nordisk (NVO) announced first results from the STEP Young phase 3 trial, evaluating once-weekly semaglutide in combination with a reduced-calorie diet and...

TipRanks 23h

Novo Nordisk Hit by Another Heart Drug Setback

Novo Nordisk (NVO) has halted two late‑stage studies of its experimental heart drug ziltivekimab, marking a major setback in its push into cardiovascular medici...

Nasdaq 1d

Novo Nordisk: STEP Young Phase 3 Trial With Semaglutide Shows Superior BMI Reduction At Week 68

(RTTNews) - Novo Nordisk (NVO, NOVOB.CO, NOV.DE) announced first results from the STEP Young phase 3 trial, evaluating once-weekly semaglutide in combination wi...

The Wall Street Journal 1d

Novo Nordisk Says Wegovy Shot Helped Children Lose Weight in Trial

Overall safety and tolerability of the drug were consistent with previous trials in children and adults. Shelby Knowles / Bloomberg Novo Nordisk NOVO.B -0.13 %...

TipRanks 2d

Clever Culture Systems Wins Expanded Novo Nordisk Order as APAS Nears Global Validation

The latest update is out from LBT Innovations Limited ( (AU:CC5) ). Clever Culture Systems Ltd, an Adelaide-based specialist in AI microbiology automation, has...

Nasdaq 3d

Viking Therapeutics Trades Well Below Its Wall Street Targets. Here's the Skeptics' Case.

Key Points Viking Therapeutics has significant upside potential based on Wall Street targets. VK2735's dual-formulation strategy could differentiate it in a c...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.